CREDITACCBSECreditAccess Grameen Ltd· FinanceHighNeutral
Announced Fri, 8 May, 2026 · 18:25 IST

Results - Quarter and Financial Year Ended March 31, 2026

CREDITACC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.1%Reaction day
₹1497.00
prior close
₹1515.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.1%-0.1% vs market
Finance peers, median of 417sector · industry level-1.0%-0.1% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Smallcap 250 and 0.1 pts less than its Finance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.1
15m
+0.0
30m
-0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.1-1.1-0.1-1.0-0.1
Next day
-6.7-4.0-2.7-3.0-3.7
2d
-10.6-3.7-6.9-3.0-7.6
3d
-11.7-3.7-8.0-3.2-8.6
4d
-12.2-4.1-8.1-3.7-8.5
5d
-13.9-5.5-8.4-4.7-9.2
1w
-13.6-4.4-9.3-4.5-9.2
15d
-12.4-2.8-9.6-5.2-7.3
1m
-15.0-4.6-10.4-6.9-8.1
2m
+2.7+4.2-1.5-4.1+6.8
3m
+3.4+5.4-2.0-4.8+8.2
UpDownMarket · Nifty Smallcap 250Sector · Finance peers, median of 417Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CreditAccess Grameen reported strong full-year FY26 results with total revenue from operations growing 5.3% to ₹6,058.92 crore from ₹5,752.33 crore. Profit after tax surged 46.3% to ₹777.64 crore versus ₹531.40 crore in the prior year, driven by a significant 39.6% reduction in impairment on financial instruments (₹1,775 crore vs ₹1,930 crore). Finance costs declined slightly to ₹1,899 crore from ₹1,948 crore. For Q4 standalone, PAT jumped over 7x to ₹339.55 crore from ₹47.21 crore in the year-ago quarter, boosted by lower impairment and strong fee income. Basic EPS for the year stood at ₹48.63. The auditors issued an unmodified opinion with no qualifications. Asset quality improved with Gross Stage III (NPA) at 3.17% and Net Stage III at 1.12%, while CRAR remained healthy at 24.41%.

Likely market impact

The sharp PAT growth of over 46% and multi-fold jump in Q4 profit signal strong operational recovery and better asset quality management. The stock is likely to react positively given the beat on earnings, though the elevated debt-equity ratio of 3.04 warrants monitoring in a rising rate environment.